Scientists at the RCSI University of Medicine and Health Sciences in Dublin, Ireland, have discovered a new role for the blood clotting protein, von Willebrand Factor (VWF), that could lead to the ...
New research by RCSI University of Medicine and Health Sciences published in the Blood Journal has revealed that the age at which individuals are tested for von Willebrand disease (VWD), a common ...
Researchers in the Boston Children's Program in Cellular and Molecular Medicine and the Harvard Medical School department of biological chemistry and molecular pharmacology have shown how the von ...
Thrombotic disorders—such as ischemic stroke, heart attack, pulmonary embolism, and deep vein thrombosis—are principal ...
Researchers developed a silicon-based nanothrombolytic therapy that efficiently dissolves blood clots while controlling the ...
New research from RCSI University of Medicine and Health Sciences has found that high levels in the bloodstream of a key protein involved in blood clotting called von Willebrand Factor, can lead to ...
New research from RCSI University of Medicine and Health Sciences has found that high levels in the bloodstream of a key protein involved in blood clotting called von Willebrand Factor, can lead to ...
BANNOCKBURN, Ill.--(BUSINESS WIRE)--Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and ...
Anna Aksenova, a senior research associate at the Laboratory of Amyloid Biology at St Petersburg University, has advanced a hypothesis that the severe course of COVID-19 may be associated with von ...
Scientists have identified the specific structural element of von Willebrand Factor that allows it to bind with platelets and initiate blood clotting. The team says that the specific unit, which they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results